Factor VIII preparations: need for prospective pharmacovigilance.
Vermylen
J
J
Department of Haematology, University of Leiden, Netherlands.
Briët
E
E
D005169:Factor VIII / Q000037:antagonists & inhibitors / Q000276:immunology / Q000592:standards*; D006467:Hemophilia A / Q000276:immunology / Q000628:therapy; D006801:Humans; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D005169:Factor VIII